Dihydromyricetin in the management of diabetes and its complications: a narrative review
Food & Function · 2026
DOI: 10.1039/d5fo03575a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food & Function, 2026. Verfasst von Wei Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China. songrenyue@cdutcm.edu.cn. Hauptthemen laut MEDLINE: Flavonols, Diabetes Mellitus, Diabetes Complications, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Dihydromyricetin shows multi-target potential in diabetes and its major complications by improving glucose and lipid metabolism, reducing oxidative stress and inflammation, providing neuroprotection, and modulating multiple molecular pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China. songrenyue@cdutcm.edu.cn.
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, W., Ding, K., Liu, X., Hu, Z., Yue, R., & Yang, M. (2026). Dihydromyricetin in the management of diabetes and its complications: a narrative review. Food & Function. https://doi.org/10.1039/d5fo03575a
Vancouver
Jiang W, Ding K, Liu X, Hu Z, Yue R, Yang M. Dihydromyricetin in the management of diabetes and its complications: a narrative review. Food & Function. 2026. doi:10.1039/d5fo03575a
BibTeX
@article{Jiang2026,
author = {Jiang, Wei and Ding, Kaixi and Liu, Xiaoqin and Hu, Zhipeng and Yue, Rensong and Yang, Maoyi},
title = {Dihydromyricetin in the management of diabetes and its complications: a narrative review},
journal = {Food & Function},
year = {2026},
doi = {10.1039/d5fo03575a}
}
EUVIMED